论文部分内容阅读
Kasai 开创的肝门部肝肠吻合术治疗胆道闭锁 (CBA)已40余年,疗效不断提高,长期存活率亦不断增加,但对本术式目前仍有争议。欧美等国学者多认为 CBA 为一进行性不可逆性疾病,肝肠吻合术难以治愈。作者对术后存活20年以上病例进行随访观察,以期对肝门部肝肠吻合术加以评价。日本东北大学小儿外科在 CBA 行肝门部肝肠吻合术300例中,术后存活20年以上者31例,其中1例于28岁时死于肝功能衰竭,另30例中,男10例,女20例,年龄20～24岁。按病理分型:Ⅰ型10例,
Kasai pioneered hepatic portal anastomosis for the treatment of biliary atresia (CBA) for more than 40 years, with continuous improvement of efficacy and long-term survival rate has also continued to increase, but the operation is still controversial. Many scholars in Europe and the United States believe that CBA is a progressive irreversible disease, which is difficult to cure. The authors of the postoperative survival of more than 20 years follow-up observation of cases, with a view to evaluate the hepatic portal anastomosis. Department of Pediatric Surgery, Northeastern University, Japan 300 cases of hepatic portal anastomosis in CBA performed 31 patients with postoperative survival for more than 20 years, of which 1 died of liver failure at the age of 28, and the other 30 patients, 10 males, 20 females, aged 20 to 24 years old. According to pathological classification: type I in 10 cases,